The Patent Finder
TB

Takara Bio Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Previously recorded as Clontech Laboratories, Inc. (to 2016)

87 patents currently held

5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
22 more records may belong here and await a decision; they are not counted.

The next term ends in Mar 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
10
Ending by 2030
Mar 2027
Next term end
54
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Methods of Depleting a Target Molecule from an Initial Collection of Nucleic Acids, and Compositions and Kits for Practicing the Same US 10,150,985
The most cited patent in this portfolio, cited by 116 later US patents, top 5% of utility patents granted in 2018 in our data. Protection runs to 2035.
Ends Sep 2035 · High confidence
Also notable
Apparatus and Method for Multiplex Analysis US 7,622,296
Cited by 85 later US patents, top 10% of utility patents granted in 2009 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Ends Jul 2027 · Medium confidence
Also notable
Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same US 10,941,397
Cited by 24 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2035.
Ends Apr 2035 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 21, 2026
    The maintenance fee for Method for Using Heat-Resistant Mismatch Endonuclease (US 10,294,465) comes due Nov 21, 2026. Unpaid by May 21, 2027, it lapses early.
  • 3 fees due Dec 6 to 16, 2026 · next Dec 6
  • 1 fee due Feb 11, 2027
    The maintenance fee for Method for Producing Virus Vector (US 9,102,943) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
  • 4 fees due Mar 15 to 24, 2027 · next Mar 15
  • 1 fee due Apr 27, 2027
    The maintenance fee for METHOD FOR SYNTHESIZING cDNA (US 9,169,482) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.
  • 1 fee due Jun 10, 2027
    The maintenance fee for Extraction of Restrained Liquid from Wells (US 10,500,585) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
  • 3 fees due Jul 5 to 30, 2027 · next Jul 5
  • 2 fees due Sep 10 to 29, 2027 · next Sep 10
  • 2 fees due Oct 16 to 28, 2027 · next Oct 16
  • 1 fee due Nov 5, 2027
    The maintenance fee for Method for Rapid Accurate Dispensing, Visualization and Analysis of Single Cells (US 10,641,772) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 21, 2026
  • 2 terms have ended since Aug 21, 2026

What they patent

The largest of its 54 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 8,927,273Process for Producing Cytotoxic Lymphocytes
In force
 · High confidence
In forceHigh confidence
US 7,622,296Apparatus and Method for Multiplex Analysis
In force
 · Medium confidence
In forceMedium confidence
US 7,846,703Method for Enhancing Polymerase Activity
In force
 · High confidence
In forceHigh confidence
US 9,132,427Apparatus for High Throughput Chemical Reactions
In force
 · High confidence
In forceHigh confidence
US 9,951,381Apparatus for High Throughput Chemical Reactions
In force
 · High confidence
In forceHigh confidence
US 9,296,807Method for Expression of Specific Gene
In force
 · High confidence
In forceHigh confidence
US 9,057,056Method for Producing Retrovirus Using Human Producer Cells with Increased N-acetylglucosaminyltransferase III Activity
In force
 · High confidence
In forceHigh confidence
US 11,643,681Apparatus for High Throughput Chemical Reactions
In force
 · Medium confidence
In forceMedium confidence
US 9,051,391Method for Expression of Specific Gene
In force
 · High confidence
In forceHigh confidence
US 9,238,797Method for Production of Pluripotent Stem Cell
In force
 · High confidence
In forceHigh confidence
10 of 87 patents shown.
Pro members see all 87.
Pro members: see all 87 patents
Also on record, not counted in the 87: 5 patents in force now held by others · 152 patents ended · 26 applications pending · 117 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited